|
PHF21A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.151000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.793400E-01 |
| Normal-vs-Stage2 |
4.807800E-01 |
| Normal-vs-Stage3 |
3.490000E-01 |
| Normal-vs-Stage4 |
9.908600E-01 |
| Stage1-vs-Stage2 |
2.588600E-01 |
| Stage1-vs-Stage3 |
1.395560E-01 |
| Stage1-vs-Stage4 |
7.823000E-01 |
| Stage2-vs-Stage3 |
8.887800E-01 |
| Stage2-vs-Stage4 |
6.711200E-01 |
| Stage3-vs-Stage4 |
5.929600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.066200E-01 |
| Normal-vs-AfricanAmerican |
7.263400E-01 |
| Normal-vs-Asian |
5.020600E-01 |
| Caucasian-vs-AfricanAmerican |
6.304800E-01 |
| Caucasian-vs-Asian |
3.215800E-01 |
| AfricanAmerican-vs-Asian |
4.352600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.974010E-01 |
| Normal-vs-Female |
4.404300E-03 |
| Male-vs-Female |
6.07000000000246E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.018600E-01 |
| Normal-vs-Extreme_Weight |
1.243990E-01 |
| Normal-vs-Obese |
1.538830E-01 |
| Normal-vs-Extreme_Obese |
1.393040E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.424800E-01 |
| Normal_Weight-vs-Obese |
3.546400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.056800E-01 |
| Extreme_Weight-vs-Obese |
6.260000E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.470000E-01 |
| Obese-vs-Extreme_Obese |
1.220170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.422170E-02 |
| Normal-vs-Age(41-60Yrs) |
1.809370E-01 |
| Normal-vs-Age(61-80Yrs) |
1.263360E-01 |
| Normal-vs-Age(81-100Yrs) |
4.616400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.158120E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.099600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.780760E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.343500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.856000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.179400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.707600E-01 |
| Normal-VS-Type2 PRCC |
1.867360E-01 |
| Normal-VS-KIRP CIMP |
8.458500E-03 |
| Normal-VS-Unclassified PRCC |
1.179390E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.659000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.90639999997355E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
6.376200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.83089999997266E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
2.031700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.937800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.716200E-01 |
| Normal-vs-N1 |
4.371800E-02 |
| Normal-vs-N2 |
4.051600E-01 |
| N0-vs-N1 |
9.620000E-03 |
| N0-vs-N2 |
3.224000E-01 |
| N1-vs-N2 |
7.195000E-01 |
|
|
